After Hours
$
19.50
Change
-0.41 -2.06%
Volume
Volume 35,382
Feb 2, 2023, 4:56 p.m.
Quotes are delayed by 20 min
Today's close
$ 18.93
$ 19.91
Change
+0.98 +5.18%
Day low
Day high
$18.95
$19.93

52 week low
52 week high
$12.24
$28.06

Market cap
$3.07B
Average volume
1.12M
P/E ratio
N/A
Rev. per Employee
$995,142
EPS
-1.35
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ACAD
-
Acadia Pharma price target reduced to $15 from $17 at Mizuho Securities USA
- Steve Gelsi
-
Acadia Pharmaceuticals price target cut to $17 from $19 at Mizuho
- Emily Bary
-
Acadia Pharmaceuticals stock price target cut to $19 from $27 at Mizuho
- Tomi Kilgore
-
Acadia Pharmaceuticals stock price target cut to $19 from $27 at Mizuho
- Tomi Kilgore
-
ACADIA stock was up 0.2% premarket prior to trading halt, after soaring 20.1% the past 2 days
- Tomi Kilgore
-
ACADIA Pharmaceuticals stock halted for news pending
- Tomi Kilgore
-
5 Biotech Stocks That Could Lead a Revival
- Barron's Online
-
5 Undervalued Healthcare Stocks
- Barron's Online
-
Travere Therapeutics' Disappointment Is Another Sign of a Tougher FDA
- Barron's Online
-
Will Biotech Stocks' Slide Become a Rout? June Holds the Key.
- Barron's Online
-
Acadia Pharmaceuticals stock price target cut to $26 from $40 at Canaccord Genuity
- Tomi Kilgore
-
Acadia Pharmaceuticals downgraded to hold at Canaccord Genuity
- Tomi Kilgore
-
Acadia Is Hit by Wave of Downgrades After FDA Rejection
- Barron's Online
-
Acadia Pharmaceuticals stock price target cut to $25 from $37 at Mizuho
- Tomi Kilgore
-
Acadia Pharmaceuticals downgraded to neutral from buy at Mizuho
- Tomi Kilgore
-
Acadia Stock Is Plunging Again. The FDA Rejected a Drug Application.
- Barron's Online
-
The FDA Is Clamping Down. What to Know.
- Barron's Online
- Loading more headlines...
Analyst Ratings
-
H.C. Wainwright: Acadia Is More Than A One-Trick Pony
- Benzinga.com
-
Pros And Cons Of All The News Out Of Acadia Pharma This Week
- Benzinga.com
Other News on ACAD
-
10-Q: ACADIA PHARMACEUTICALS INC
- Edgar Online - (EDG = 10Q, 10K)
- Loading more headlines...
Press Releases on ACAD
-
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
- BusinessWire - BZX
-
Acadia Pharmaceuticals Reports Third Quarter 2022 Financial Results
- BusinessWire - BZX
-
Acadia Pharmaceuticals Appoints Adora Ndu, Pharm.D., J.D. to its Board of Directors
- BusinessWire - BZX
-
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
- BusinessWire - BZX
-
Acadia Pharmaceuticals Reports Second Quarter 2022 Financial Results
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com